Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
RedHill Biopharma Reports 2017 Third Quarter Financial Results
-
Endo Int'l (ENDP): Good Results But No Visibility, PT To $7 at Cantor
-
Dynavax Technologies (DVAX) PT Raised to $25 at Cantor Fitzgerald Following Approval of HEPLISAV-B
-
Form 4 BGC Partners, Inc. For: Nov 07 Filed by: CANTOR FITZGERALD, L. P.
-
CytoSorbents Continues Strong Trajectory of Growth in the Third Quarter 2017
-
Impax Laboratories (IPXL) PT Raised to $35 at Cantor Fitzgerald
-
Avino Reports Q3 2017 Financial Results
-
Orchid Island Capital Announces November 2017 Monthly Dividend and October 31, 2017 RMBS Portfolio Characteristics
-
RedHill Biopharma (RDHL) Prices 4.1M ADS Offering at $5.50/Sh
-
RedHill Biopharma Prices Public Offering of its American Depositary Shares
-
RedHill Biopharma Prices Public Offering of its American Depositary Shares
-
RedHill Biopharma (RDHL) Plans Offer of ADSs
-
RedHill Biopharma Announces Proposed Public Offering of its American Depositary Shares
-
RedHill Biopharma Announces Proposed Public Offering of its American Depositary Shares
-
Mallinckrodt plc (MNK) PT Lowered to $42 at Cantor Fitzgerald; Remains 'Overweight'
-
Cantor Fitzgerald Is Positive On Valeant Pharma (VRX), Reiterates Overweight and $23 Price Target
-
ProPhotonix Extends Laser Modules Offering in Agreement with Integrated Optics
-
Tivity Health (TVTY) Defended at Cantor Fitzgerald; UNH Contract Runs Through 2020
-
Haymaker Acquisition Corp. Announces Closing of Underwriters’ Over-Allotment Option in Connection with its Initial Public Offering
-
HMS Holdings (HMSY) PT Lowered to $16 at Cantor Fitzgerald, Keeps 'Overweight'
-
M III Acquisition Corp. and IEA Energy Services LLC Announce Signing of Merger Agreement for Business Combination
-
Cantor Fitzgerald Positive on Valeant (VRX) Amid Vyzulta Approval
-
Teva Pharma (TEVA) PT Slashed to $10 at Cantor Fitzgerald
-
Freddie Mac Prices $1 Billion Multifamily K-Deal, K-728
-
AMAG Pharmaceuticals (AMAG) PT Lowered to $17 at Cantor Fitzgerald
-
Zoetis Inc. (ZTS) PT Raised to $80 at Cantor Fitzgerald
-
NewLink Genetics Reports Third Quarter 2017 Financial Results and Updates Indoximod Program
-
Facebook (FB) PT Raised to $220 at Cantor Fitzgerald, Remains Top Pick
-
Cantor Fitzgerald Upgrades Intercept Pharmaceuticals (ICPT) to Neutral
-
bluebird bio (BLUE) PT Raised to $58 at Cantor Fitzgerald
-
Allergen (AGN) PT Lowered to $191 at Cantor Fitzgerald
-
Kevin Raidy Named Managing Partner of Cowen Healthcare Investments
-
UPDATE: Cantor Fitzgerald Downgrades Envision Healthcare (EVHC) to Neutral
-
ProPhotonix Adds New High-Power Ushio Red Laser diodes to Product Range
-
Haymaker Acquisition Corp. Announces Closing of $300,000,000 Initial Public Offering
-
Cantor Fitzgerald Downgrades Celgene (CELG) to Neutral
-
Cantor Fitzgerald Downgrades Aetna (AET) to Neutral
-
Orchid Island Capital Announces Third Quarter 2017 Results
-
Cantor Fitzgerald Starts McEwen Mining (MUX) at Overweight (Yesterday)
-
OPKO Health (OPK) on Watch as FDA Approves Partner TESARO's VARUBI
-
Anthem (ANTM) PT Raised to $226 at Cantor Fitzgerald
-
Haymaker Acquisition Corp. Announces Pricing of $300,000,000 Initial Public Offering
-
UPDATE: Cantor Fitzgerald Starts Aldeyra Therapeutics (ALDX) at Overweight
-
Centene (CNC) Sell-Off 'Overdone' - Cantor Fitzgerald
-
Corbus Pharma (CRBP) Prices 4.65M Common Stock Offering at $7/Share
-
Corbus Pharmaceuticals Holdings, Inc. Prices Underwritten Public Offering of Common Stock
-
Cantor Fitzgerald Starts CytomX Therapeutics (CTMX) at Overweight
-
Corbus Pharma (CRBP) Announces Proposed Public Common Offering
-
Corbus Pharmaceuticals Holdings, Inc. Announces Proposed Public Offering of Common Stock
-
First RealFund Launches Investor-Aligned Commercial Real Estate Crowdfunding Platform - Partnering Astute Owners with Accredited Investors

